Please Wait.....
Report
Global Contraceptive Devices Market Report and Forecast 2023-2031
Market Report I 2023-04-18 I 140 Pages I EMR Inc.
Global Contraceptive Devices Market Report and Forecast 2023-2031
Global Contraceptive Devices Market Outlook
The global contraceptive devices market size attained a value of about USD 10.86 billion in 2022. The market is anticipated to grow further at a CAGR of 6.55% during the forecast period of 2023-2031 to attain a value of USD 19.23 billion by 2031.
Contraceptive Devices Market: Introduction
Contraceptive devices are medical tools, devices, or methods used to prevent pregnancy by blocking or reducing the chances of fertilization or implantation of a fertilized egg. These devices can be used by men or women, and they come in various forms, including hormonal, barrier, intrauterine devices (IUDs), sterilization, and others. Hormonal contraceptive devices contain hormones that prevent ovulation or thicken cervical mucus, making it difficult for sperm to reach the egg. Barrier devices, such as condoms and diaphragms, physically prevent sperm from reaching the egg. IUDs are inserted into the uterus and can prevent fertilization and implantation. Sterilization procedures are permanent and involve blocking or cutting the fallopian tubes in women or vas deferens in men. The choice of contraceptive device depends on various factors such as individual preference, medical history, and lifestyle.
The global contraceptive devices market is a growing industry driven by increasing awareness about birth control, the rising incidence of sexually transmitted infections (STIs), and the need for family planning. The market for contraceptive devices is segmented into various categories such as hormonal, barrier, intrauterine devices (IUDs), sterilization, and others. The hormonal segment is expected to dominate the market during the forecast period due to the high efficacy rate and ease of use of hormonal contraceptives. The intrauterine devices (IUDs) segment is also expected to witness significant growth due to the increasing adoption of long-acting reversible contraceptives (LARC) and the availability of newer and more advanced IUDs in the market.
Geographically, the global contraceptive devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the largest share of the market in the historical period owing to the high demand for contraceptives and the presence of well-established healthcare infrastructure. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, owing to the large population base and increasing awareness about birth control.
Contraceptive Devices Market Segmentations
Market Breakup by Product Type
- Male Contraceptive Devices
o Condoms
o Spermicides
- Female Contraceptive Devices
o Female Condoms
o Contraceptive Sponges
o Contraceptive Vaginal Rings
o Intrauterine Devices
o Sub-dermal Contraceptive Implants
o Non-Surgical Permanent Contraceptive Devices
Market Breakup by Technology
- Hormonal Contraceptives
- Barrier Contraceptives
Market Breakup by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Channel
- Public Channel
- Others
Contraceptive Devices Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Developments in the Contraceptive Devices Market
Introduction of long-acting reversible contraceptives (LARC): LARC, such as intrauterine devices (IUDs) and contraceptive implants, are gaining popularity due to their high efficacy rates and convenience of use. Companies are investing in the development of newer and more advanced LARC options to cater to the growing demand.
Increasing focus on male contraception: Male contraception is a largely untapped market, but there is growing interest in the development of new male contraceptive options. Companies are investing in research and development to create safe and effective male contraceptive products.
Growing demand for non-hormonal contraceptive options: Hormonal contraceptives have been the dominant option for birth control for many years, but there is a growing demand for non-hormonal options due to concerns about side effects and health risks. Companies are developing newer non-hormonal contraceptive options such as copper IUDs and fertility tracking devices.
Adoption of digital health technologies: There is a growing trend towards the use of digital health technologies such as mobile apps and wearable devices for birth control and family planning. Companies are developing innovative digital health solutions to cater to this growing demand.
Mergers and acquisitions: The contraceptive devices market is highly competitive, and companies are looking to strengthen their position in the market through mergers and acquisitions. For instance, in 2020, Mylan merged with Pfizer's Upjohn business to create Viatris Inc., a global healthcare company with a diverse portfolio of products including contraceptive devices.
Key Players in the Global Contraceptive Devices Market
The report gives an in-depth analysis of the key players involved in the contraceptive devices market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
- Bayer AG
- Pfizer Inc.
- Janssen Global Services, LLC
- Teva Pharmaceutical Industries Ltd.
- Merck Sharp & Dohme Corp.
- Mylan N.V.
- Reckitt Benckiser Group plc.
- Veru Inc.
- Medisafe Distribution Inc.
- CooperSurgical, Inc.
- Devex
- Mayer Laboratories, Inc.
- Allergan plc.
- Agile Therapeutics
- HLL Lifecare
- ANSELL LTD
- Mankind Pharma
- TTK HealthCare
- Boehringer Ingelheim International GmbH.
- V-Care Pharma Pvt. Ltd.
- VARDHAMAN LIFECARE PVT LTD
- Cipla Inc.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Contraceptive Devices Market Overview
3.1 Global Contraceptive Devices Market Historical Value (2016-2022)
3.2 Global Contraceptive Devices Market Forecast Value (2023-2031)
4 Global Contraceptive Devices Market Landscape
4.1 Global Contraceptive Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Contraceptive Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Distribution Channel
5 Global Contraceptive Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Contraceptive Devices Market Segmentation
6.1 Global Contraceptive Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Male Contraceptive Devices
6.1.2.1 Condoms
6.1.2.2 Spermicides
6.1.3 Female Contraceptive Devices
6.1.3.1 Female Condoms
6.1.3.2 Contraceptive Sponges
6.1.3.3 Contraceptive Vaginal Rings
6.1.3.4 Intrauterine Devices
6.1.3.5 Sub-dermal Contraceptive Implants
6.1.3.6 Non-Surgical Permanent Contraceptive Devices
6.2 Global Contraceptive Devices Market by Technology
6.2.1 Market Overview
6.2.2 Hormonal Contraceptives
6.2.3 Barrier Contraceptives
6.3 Global Contraceptive Devices Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospital Pharmacy
6.3.3 Retail Pharmacy
6.3.4 Online Channel
6.3.5 Public Channel
6.3.6 Others
6.4 Global Contraceptive Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Contraceptive Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Contraceptive Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Contraceptive Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Contraceptive Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Contraceptive Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Bayer AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Pfizer Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Janssen Global Services, LLC
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Teva Pharmaceutical Industries Ltd.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Merck Sharp & Dohme Corp.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Mylan N.V.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Reckitt Benckiser Group plc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Veru Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Medisafe Distribution Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 CooperSurgical, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Devex
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Mayer Laboratories, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Allergan plc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Agile Therapeutics
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 HLL Lifecare
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 ANSELL LTD
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 Mankind Pharma
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 TTK HealthCare
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 Boehringer Ingelheim International GmbH.
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
17.20 V-Care Pharma Pvt. Ltd.
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.20.5 Certifications
17.21 VARDHAMAN LIFECARE PVT LTD
17.21.1 Financial Analysis
17.21.2 Product Portfolio
17.21.3 Demographic Reach and Achievements
17.21.4 Mergers and Acquisitions
17.21.5 Certifications
17.22 Cipla Inc.
17.22.1 Financial Analysis
17.22.2 Product Portfolio
17.22.3 Demographic Reach and Achievements
17.22.4 Mergers and Acquisitions
17.22.5 Certifications
18 Global Contraceptive Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security